Ascentage Pharma corrects timing for August 19 interim results release
The company revised the start time of its six-month 2026 results webcast to 7:00 am EDT after an earlier release listed 9:00 am EDT in error.
SEC filing
Latest
2 stories
Thursday, August 13
Monday, August 3
Ascentage Pharma names new Chief Business Officer and Chief Commercial Officer
The company appointed Dr. Faiçal Miyara as CBO and Jim Ziegler as CCO on August 2, 2026, dividing global deal-making from U.S. and ex-China commercial duties.
SEC filing